EFTA01110900.pdf

Investors engagement sheet for Ehud Barak - Confidential Background Following our meeting on 5-April-2016, we have prepared per your guidance: • Levitection — investors briefing - short PDF document you can use freely with others as well • This document — For yourself only. To hove the additional financial terms What are we looking for? We are looking to start the heavy-lifting part for developing Q. as follow: Stage Estimated timeline Estimated Cost Stogel: 0 Prototype 12 Months 1.5 - 2 M Dollars fOCS approved 320 KS] Stoge2: 0 Beta product 18 Months 3.5 - 4 M Dollars (Potential to further involve OCS) OCS = Office of the Chief Scientist In order to start the above, we are looking for funding of stage', as per the details above. [2M — OCS Investment = 1.7M Dollars]. The funding can be done in multiple steps, with minimum first step of 320 K$, matching OCS funding that was approved. Stage 1: Stage 2: Prototype Build Beta Product Seed Round $1 Post Seed Round ta Post What is in it for the investor? Company value = 5M$ Evaluate Company value = 19M5 Evaluate As requested, attached table summarizes and simulates the funds in K$ % 15,000 funds in K$ % 30.000 1,700 33% 4,904 26% 7,743 future scenario of equity for investments in 2 stages: 4,000 21% 6,316 Stogel (Seed Roundi): Total investment (can represent also a Total: 47% 14,059 group of investors) of 1.7M Dollars for 33% of ordinary shares, will enable us to build the Seed roundl Q prototype. This step will yield a company value of 5M$ for the Seed-Round. Following a successful prototype, company evaluation is expected to elevate to 15 M$, ■ ESOP and with that the value of shares for our investors from 1.7M$ to 4.9M$. ■ Investors ■ Founder Stoge2 (Seed Round2): Total additional investment of 4M Dollars for 21%, will enable us to build the Q Beta product. This step will yield a company value of 19 M$ for this round. This round will bring the investors percentage to 47% (as per Cake split). Seed Round2 Following a successful deployment of Beta Product, company evaluation is expected to elevate to 30 M$, and with that the value of shares for our investors from to 14M$. Note: This model shows a scenario that we will allocate 10% for ESOP in pre-round. EFTA01110900